ACEX - Cappai,R.; Jobling,M.F.; Barrow,C.J.; Collins,S.J. - Structural biology of prions - Contributions to Microbiology 2001; 7: 32-47
ACEY - Cappai,R.; Stewart,L.; Jobling,M.F.; Thyer,J.M.; White,A.R.; Beyreuther,K.; Collins,S.J.; Masters,C.L.; Barrow,C.J. - Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation. - Biochemistry 1999 Mar 16; 38(11): 3280-4
AFBJ - Hamilton,J.A.; Whitty,G.; White,A.R.; Jobling,M.F.; Thompson,A.; Barrow,C.J.; Cappai,R.; Beyreuther,K.; Masters,C.L. - Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF) - Brain Research 2002 Jun 14; 940(1-2): 49-54
AGAY - Jobling,M.F.; Huang,X.; Stewart,L.R.; Barnham,K.J.; Curtain,C.C.; Volitakis,I.; Perugini,M.; White,A.R.; Cherny,R.A.; Masters,C.L.; Barrow,C.J.; Collins,S.J.; Bush,A.I.; Cappai,R. - Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126 - Biochemistry 2001 Jul 10; 40(27): 8073-84
AGAZ - Jobling,M.F.; Stewart,L.R.; White,A.R.; McLean,C.; Friedhuber,A.; Maher,F.; Beyreuther,K.; Masters,C.L.; Barrow,C.J.; Collins,S.J.; Cappai,R. - The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126 - Journal of Neurochemistry 1999 Oct; 73(4): 1557-65
AOGL - Kourie,J.I.; Kenna,B.L.; Tew,D.; Jobling,M.F.; Curtain,C.C.; Masters,C.L.; Barnham,K.J.; Cappai,R. - Copper modulation of ion channels of PrP[106-126] mutant prion peptide fragments - Journal of Membrane Biology 2003 May 1; 193(1): 35-45
ALEH - Stewart,L.R.; White,A.R.; Jobling,M.F.; Needham,B.E.; Maher,F.; Thyer,J.; Beyreuther,K.; Masters,C.L.; Collins,S.J.; Cappai,R. - Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126 - Journal of Neuroscience Research 2001 Sep 15; 65(6): 565-72
ANSX - White,A.R.; Maher,F.; Brazier,M.W.; Jobling,M.F.; Thyer,J.; Stewart,L.R.; Thompson,A.; Gibson,R.; Masters,C.L.; Multhaup,G.; Beyreuther,K.; Barrow,C.J.; Collins,S.J.; Cappai,R. - Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation - Brain Research 2003 Mar 21; 966(2): 231-44
AMKN - White,A.R.; Guirguis,R.; Brazier,M.W.; Jobling,M.F.; Hill,A.F.; Beyreuther,K.; Barrow,C.J.; Masters,C.L.; Collins,S.J.; Cappai,R. - Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons - Neurobiology of Disease 2001 Apr; 8(2): 299-316
AMKO - White,A.R.; Huang,X.; Jobling,M.F.; Barrow,C.J.; Beyreuther,K.; Masters,C.L.; Bush,A.I.; Cappai,R. - Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. - Journal of Neurochemistry 2001 Mar; 76(5): 1509-20
AMKP - White,A.R.; Collins,S.J.; Maher,F.; Jobling,M.F.; Stewart,L.R.; Thyer,J.M.; Beyreuther,K.; Masters,C.L.; Cappai,R. - Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity - American Journal of Pathology 1999 Nov; 155(5): 1723-30